Follow
Andreas Reichel
Andreas Reichel
Bayer AG
Verified email at bayer.com
Title
Cited by
Cited by
Year
Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro
RN Alyaudtin, A Reichel, R Löbenberg, P Ramge, J Kreuter, DJ Begley
Journal of drug targeting 9 (3), 209-221, 2001
2592001
Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept
A Reichel
Chemistry & biodiversity 6 (11), 2030-2049, 2009
1922009
An overview of in vitro techniques for blood-brain barrier studies
A Reichel, DJ Begley, NJ Abbott
The Blood-Brain Barrier: Biology and Research Protocols, 307-324, 2003
1772003
The Lab Oddity Prevails: Discovery of Pan‐CDK Inhibitor (R)‐S‐Cyclopropyl‐S‐(4‐{[4‐{[(1R,2R)‐2‐hydroxy‐1‐methylpropyl]oxy}‐5‐(trifluoromethyl)pyrimidin‐2 …
U Lücking, R Jautelat, M Krüger, T Brumby, P Lienau, M Schäfer, H Briem, ...
ChemMedChem 8 (7), 1067-1085, 2013
1762013
The role of blood-brain barrier studies in the pharmaceutical industry
A Reichel
Current drug metabolism 7 (2), 183-203, 2006
1752006
Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female …
C MacLean, U Moenning, A Reichel, G Fricker
Drug Metabolism and Disposition 36 (7), 1249-1254, 2008
1742008
Mechanism-based inhibition: deriving KI and kinact directly from time-dependent IC50 values
BF Krippendorff, R Neuhaus, P Lienau, A Reichel, W Huisinga
SLAS Discovery 14 (8), 913-923, 2009
1672009
Potential of immobilized artificial membranes for predicting drug penetration across the blood− brain barrier
A Reichel, DJ Begley
Pharmaceutical research 15, 1270-1274, 1998
1661998
Drug resistance in epilepsy: the role of the blood–brain barrier
NJ Abbott, EU Khan, CMS Rollinson, A Reichel, D Janigro, ...
Mechanisms of Drug Resistance in Epilepsy: Novartis Foundation Symposium 243 …, 2002
1642002
Straightforward strategies for the preparation of NH-sulfoximines: a serendipitous story
JA Bull, L Degennaro, R Luisi
Synlett 28 (19), 2525-2538, 2017
1312017
Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines
M Chishty, A Reichel, J Siva, NJ Abbott, DJ Begley
Journal of drug targeting 9 (3), 223-228, 2001
1112001
Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats
D Mitschke, A Reichel, G Fricker, U Moenning
Drug Metabolism and Disposition 36 (6), 1039-1045, 2008
972008
Pharmacokinetics in drug discovery: an exposure-centred approach to optimising and predicting drug efficacy and safety
A Reichel, P Lienau
New approaches to drug discovery, 235-260, 2016
942016
Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery
BF Krippendorff, P Lienau, A Reichel, W Huisinga
Journal of Biomolecular Screening 12 (1), 92-99, 2007
782007
Piperidine renin inhibitors: from leads to drug candidates
HP Märki, A Binggeli, B Bittner, V Bohner-Lang, V Breu, D Bur, ...
Il Farmaco 56 (1-2), 21-27, 2001
712001
Development and application of physiologically based pharmacokinetic‐modeling tools to support drug discovery
C Lüpfert, A Reichel
Chemistry & biodiversity 2 (11), 1462-1486, 2005
702005
Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development
I Loryan, A Reichel, B Feng, C Bundgaard, C Shaffer, C Kalvass, ...
Pharmaceutical research 39 (7), 1321-1341, 2022
602022
Trends in molecular properties, bioavailability, and permeability across the bayer compound collection: miniperspective
DH O’Donovan, C De Fusco, L Kuhnke, A Reichel
Journal of medicinal chemistry 66 (4), 2347-2360, 2023
482023
N-glycosylation of ABC transporters is associated with functional activity in sandwich-cultured rat hepatocytes
V Draheim, A Reichel, W Weitschies, U Moenning
European journal of pharmaceutical sciences 41 (2), 201-209, 2010
482010
Piperazine derivatives that destabilize androgen receptors
A Cleve, C Huwe, V Schulze, H Morack, D Zopf, J Hoffmann, A Reichel
US Patent 6,861,432, 2005
472005
The system can't perform the operation now. Try again later.
Articles 1–20